<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
XERS
Xeris Biopharma
$
()


  • Xeris Biopharma initiated with bullish view at Oppenheimer, here's why

    3/27/2024 - 16:09pm
  • Acelyrin price target raised by $2 at Wells Fargo, here's why

    3/20/2024 - 17:00pm
  • Biotech Alert: Searches spiking for these stocks today

    3/8/2024 - 10:46am
  • Xeris Biopharma price target raised by 50c at H.C. Wainwright, here's why

    3/7/2024 - 06:11am
  • What You Missed On Wall Street On Wednesday

    3/6/2024 - 16:17pm
  • What You Missed On Wall Street This Morning

    3/6/2024 - 12:01pm
  • Xeris Biopharma refinances senior secured term loan agreement with Hayfin

    3/6/2024 - 07:25am
  • Xeris Biopharma sees FY24 revenue $$170M-$200M, consensus $188.01M

    3/6/2024 - 07:20am
  • Xeris Biopharma reports Q4 EPS (10c), consensus (10c)

    3/6/2024 - 07:18am
  • Biotech Alert: Searches spiking for these stocks today

    2/16/2024 - 11:22am
  • What You Missed On Wall Street On Wednesday

    1/10/2024 - 16:19pm
  • What You Missed On Wall Street This Morning

    1/10/2024 - 12:04pm
  • Xeris license pact with $75M potential for Xeriject formulation of teprotumumab

    1/10/2024 - 08:14am
  • Xeris Biopharma sees FY23 revenue at 'top' of previous view $160M - $165M

    1/4/2024 - 07:07am
  • Xeris Biopharma price target lowered to $5.50 from $6 at H.C. Wainwright

    11/13/2023 - 06:09am
dynamic_feed Breaking News